ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PRTC Puretech Health Plc

214.00
1.50 (0.71%)
Last Updated: 15:40:50
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health Plc LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 0.71% 214.00 213.00 214.50 225.00 211.00 219.00 536,441 15:40:50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Home Health Care Services 23.75M -50.35M -0.1839 -11.66 587.44M
Puretech Health Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 212.50p. Over the last year, Puretech Health shares have traded in a share price range of 139.00p to 242.00p.

Puretech Health currently has 273,866,153 shares in issue. The market capitalisation of Puretech Health is £598.40 million. Puretech Health has a price to earnings ratio (PE ratio) of -11.88.

Puretech Health Share Discussion Threads

Showing 1351 to 1374 of 2000 messages
Chat Pages: Latest  56  55  54  53  52  51  50  49  48  47  46  45  Older
DateSubjectAuthorDiscuss
30/9/2021
11:37
Hopefully that’s a bit of a clue, would generate significant interest I expect.
lendmeafiver
30/9/2021
09:52
I've already given up on the LSE to work out what positive phase2 results for LYT100 for long Covid should do for the share price......no I've full confidence that the Nasdaq will be the front runners there.
volvo
30/9/2021
07:34
lmaf, yes Puretech have been banging the drum throughout September for LYT100, they must know early results look good re Long Covid.

Directors buying too.

Check out Puretech Twitter.....seems a lead into news

PureTech
@PureTechH
·
21 September 2021
Progressive fibrosing interstitial lung diseases impact >850,000 people globally, yet currently available treatments don’t meet patients’ needs & ~75% of #IPF patients are not on treatment. This #PFMonth, we’re spotlighting our dedication to helping patients with IPF & #LongCovid

Would be slightly red faced if LYT100 wasnt a success in Long Covid phase2 trials

volvo
29/9/2021
19:08
Long Covid will interest the market.
lendmeafiver
29/9/2021
16:26
Strong Akili news today.

Markets sanguine atm.

volvo
28/9/2021
17:47
Well i've topped up today sub 350p to double my current position.

News on LYT100 in long covid due anytime, which will read v good, but imo phase 2 results for VE303 for Vedanta (41pc owned) will be game changer.

Lets see what happens

volvo
28/9/2021
12:03
Buy at 11am, sell at 4pm, rinse repeat.
lendmeafiver
28/9/2021
11:58
Agree, someone was collecting stock at 372-377p this morning, great intraday trading stock
volvo
28/9/2021
11:53
What’s the betting this finishes the day back at 368p?
lendmeafiver
27/9/2021
17:19
Started good like news coming
volvo
27/9/2021
17:18
....we'll be millionaires
volvo
26/9/2021
18:19
This week......
volvo
23/9/2021
19:08
379p in US
volvo
23/9/2021
10:42
It will get back into the £4s without news if the buying continues, particularly on the Nasdaq.
lendmeafiver
23/9/2021
08:46
lmaf over 380p on first show.

Really wants to motor on here, just needs some news.

Maybe soon who knows

volvo
22/9/2021
19:40
Yes it was an interesting update on Glyph Technology.

Nasdaq volume continues to improve, next target on LSE 380, don’t think it will be long.

lendmeafiver
22/9/2021
15:26
“What’s remarkable about this study is that the COX-2 inhibitor was able to meaningfully repattern the chaotic lymphatic structure in obese mice when it was delivered directly to the mesenteric lymphatics with our Glyph technology platform, and that repatterning was accompanied by a substantial decrease in both weight gain and insulin resistance,” said Joseph Bolen, Ph.D., Chief Scientific Officer at PureTech. “We are excited to continue to build off of this pioneering research to identify and advance new potential treatment applications of this platform.”
rambutan2
22/9/2021
14:50
Lots of buying again today.
lendmeafiver
22/9/2021
09:19
Expecting Vedanta news re VE303 this month......
volvo
21/9/2021
15:03
as one of my largest holdings is novo nordisk this is bitter sweet!
edwardt
21/9/2021
06:40
lmaf....yes 7.3pc up, 387p,in a awful market day, yesterdays news was obviously better received by people on the Nasdaq who can evaluate these things.

Looks like we have a cure for obesity!

volvo
20/9/2021
21:34
Looking good on the Nasdaq this evening.
lendmeafiver
20/9/2021
17:47
Glyph technology.....4pm news....LSE so what
volvo
20/9/2021
09:40
Very strong here today in weak markets, following threw on last weeks rise and strong volume, lets see what the US wakes up like, but my thoughts are the new investor is stateside.
volvo
Chat Pages: Latest  56  55  54  53  52  51  50  49  48  47  46  45  Older

Your Recent History

Delayed Upgrade Clock